Skip to content

GI Cancers

US Focus Meeting 2026

📍 Estancia La Jolla Hotel, 9700 N Torrey Pines Rd, La Jolla, CA 92037

🗓️ July 24-25, 2026

Last Year's Highlights

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the GI Cancers Focus Meeting 2026, to be held on July 24 - 25, 2026.

Centered around the theme “Updating Knowledge & Clinical Practice in 2026” this meeting provides pivotal collaboration aimed at advancing GI Cancers research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

 

Chairs of Cell Therapy & Bispecifics US Focus Meeting 2026:

Tanios-Saab

Tanios Bekaii-Saab
Mayo Clinic, Phoenix, AZ

Eileen-OReilly

Eileen M. O’Reilly
Memorial Sloan Kettering Cancer Center, New York City, NY

Thanks to Our Supporters

Platinum

jazz-pharma

Gold

astrazeneca
BMS_square
Exelixis
Genentech_Logo
Pfizer -Oncology_Signature_Color_CMYK
revolution-medicines

Silver

GSK_Logo
servier
Takeda_Logo

Additional support provided by Boehringer Ingelheim

Agenda & Faculty

July 24, 2026 | Day 1

07:00 AM
Registration Opens
08:45 AM
Coffee Break

Session I: Pancreas Cancer
Moderated by:

Tanios-Saab

Tanios Bekaii-Saab
Mayo Clinic, Phoenix, AZ


09:05 AM
First-line Chemotherapeutic Options in mPDAC

GB

Gregory Botta
UC San Diego Health, CA
09:25 AM
RAS Directed-Therapies in mPDAC
Eileen-OReilly
Eileen M. O’Reilly
Memorial Sloan Kettering Cancer Center, New York City, NY
09:45 AM
Targeted (Excluding RAS Directed) Therapies in mPDAC
Michael-Pishvaian-1
Michael J. Pishvaian
Johns Hopkins Medicine, Baltimore, MD
10:05 AM
Panel Discussion
10:25 AM
Coffee Break

Session II: Biliary Tract Cancers (BTC)
Moderated by:

Mitesh-Borad

Mitesh Borad
Mayo Clinic, Phoenix, AZ

10:45 AM
Targeted Therapies in Advanced BTC
Tanios-Saab
Tanios Bekaii-Saab
Mayo Clinic, Phoenix, AZ
11:05 AM
1L Options on Advanced BTC
Richard-Kim
Richard Kim
Moffitt Cancer Center, Tampa, FL
11:25 AM
Emerging Treatment Landscape in Early-stage BTC
Lipika-Goyal
Lipika Goyal
Stanford Medicine, CA
11:45 AM
Panel Discussion
12:05 PM
Lunch Break + Faculty and Fellow Photo

Session III: Hepatocellular Cancer (HCC)
Moderated by:

Tanios-Saab

Tanios Bekaii-Saab
Mayo Clinic, Phoenix, AZ

12:55 PM
Navigating First-line Treatment Options in HCC
Anthony-El-Khoueiry
Anthony El-Khoueiry
USC Norris Comprehensive Cancer Center, Los Angeles, CA
1:15 PM
Second-line Options in HCC in the Era of Immunotherapy
Ghassan-Abou-Alfa
Ghassan K. Abou-Alfa
Memorial Sloan Kettering Cancer Center, New York, NY
1:35 PM
Integrating Systemic Therapy in Early-stage HCC
Richard-Finn
Richard Finn
UCLA, Santa Monica, CA
1:55 PM
Panel Discussion
2:15 PM
Coffee Break

Session IV: Neuroendocrine Tumors (NET)
Moderated by:

Mohamad-Sonbol

Mohamad Bassam Sonbol
Mayo Clinic, Phoenix, AZ

2:35 PM
The Role of Peptide Receptor Radionuclide Therapy (PRRT) in NET
Mohamad-Sonbol
Mohamad Bassam Sonbol
Mayo Clinic, Phoenix, AZ
2:55 PM
The Role of TKIs in NET
Jennifer-Chan
Jennifer Chan
Dana-Farber Cancer Institute, Boston, MA
3:15 PM
Systemic Therapy Opportunities in Earlystage NET
Thorvardur-Halfdanarson
Thorvardur R. Halfdanarson
Mayo Clinic, Rochester, MN
3:35 PM
Panel Discussion
3:55 PM
Adjourn

Agenda & Faculty

July 25, 2026 | Day 2

08:00 AM
Registration Opens
08:45 AM
Coffee Break

Session V: Esophagogastric Cancer (EGC)
Moderated by:

Bassel-El-Reyes

Bassel El-Reyes
UC San Diego Health / Moores Cancer Center, San Diego, CA


9:05 AM
Expanding the Role of Targeted Therapies in Advanced ECG
Elena-Elimova
Elena Elimova
The Princess Margaret Cancer Centre, Toronto, Canada
9:25 AM
Immunotherapy Options in Advanced EGC: Who is a Candidate?
Nataliya-Uboha
Nataliya Uboha
UW Health, Madison, WI
9:45 AM
Perioperative Strategies in EGC: An Evolving Landscape
Mohamad-Sonbol
Mohamad Bassam Sonbol
Mayo Clinic, Phoenix, AZ
10:05 AM
Panel Discussion
10:25 AM
Coffee Break

Session VI: Metastatic Colorectal Cancer (mCRC)
Moderated by:

Christopher-Lieu

Christopher Lieu
University of Colorado Anschutz Medical Campus, Aurora, CO

10:45 AM
Understanding the Role of HER2 in mCRC and Overcoming Mechanisms of Resistance
John-Strickler-1
John Strickler
Duke University, Durham, NC
11:05 AM
Targeting the MAPK Pathway in mCRC
Christopher-Lieu
Christopher Lieu
University of Colorado Anschutz Medical Campus, Aurora, CO
11:25 AM
The Potential for Immunotherapy in MSS mCRC
Kristen-Ciombor-1
Kristen Ciombor
Vanderbilt University Medical Center, Nashville, TN
11:45 AM
Panel Discussion
12:05 PM
Lunch Break

Session VII: Early-Stage CRC
Moderated by:

Cathy-Eng

Cathy Eng
Vanderbilt University Medical Center, Nashville, TN

12:55 PM
MSI-H Colon and Rectal Cancers and Emerging Options
Michael-Overman-1
Michael Overman
MD Anderson Cancer Center, Houston, TX
1:15 PM
Moving Away from Trimodality Therapy for MSS Rectal Cancer
Joshua-Smith
Joshua Smith
MD Anderson Cancer Center, Houston, TX
1:35 PM
The Role of MRD in Early Stage CRC
Bassel-El-Reyes
Bassel El-Reyes
UC San Diego Health / Moores Cancer Center, San Diego, CA
1:55 PM
Panel Discussion
2:15 PM
Coffee Break

Session VIII:Managing “The Rare"
Moderated by:

Eileen-OReilly

Eileen M. O’Reilly
Memorial Sloan Kettering Cancer Center, New York City, NY

2:35 PM
Emerging Strategies in the Treatment of GIST
Jonathan-Trent
Jonathan Trent
University of Miami Miller School of Medicine, Miami, FL
2:55 PM
Managing Rare Fusions (NTRK, RET and others)
Mitesh-Borad
Mitesh Borad
Mayo Clinic, Phoenix, AZ
3:15 PM
Managing Rare Fusions (NTRK, RET and others)
Cathy-Eng
Cathy Eng
Vanderbilt University Medical Center, Nashville, TN
3:35 PM
Panel Discussion
3:55 PM
Adjourn

Alex Worthington
Project Manager

How long has Alex Worthington been in the business?

Alex Worthington has been with MD Education since 2024.

About Alex Worthington

As Project Manager, I work to ensure the smooth running of events, assisting in the search process, outreach, organization, and the maintenance of any event. Having a diverse career background working around the world, I pride myself on networking and creating positive relationships seamlessly with all attendees.

Alex-Worthington 2